Dr. Danny Barlev, M.D
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 459
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
OH license 35.133853 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Uh Cleveland Medical Center Cleveland, OH
- Uh Regional Hospitals Chardon, OH
Medical groups
- University Hospitals Medical Group Inc (2,294 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 459
- Services billed
- 1,994
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 544 | 83 |
| Established patient office or other outpatient visit, 20-29 minutes | 297 | 217 |
| Biopsy of related skin growth, first growth | 144 | 124 |
| Destruction of precancer skin growth, 1 growth | 144 | 108 |
| Established patient office or other outpatient visit, 30-39 minutes | 70 | 57 |
| New patient office or other outpatient visit, 30-44 minutes | 69 | 69 |
| Biopsy of related skin growth, each additional growth | 55 | 40 |
| Destruction of skin growth, 1-14 growths | 42 | 36 |
| Established patient office or other outpatient visit, 10-19 minutes | 31 | 26 |
| New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ketoconazole Other prescribers in Cleveland, OH | 172 |
| Clobetasol Propionate Other prescribers in Cleveland, OH | 134 |
| Triamcinolone Acetonide Other prescribers in Cleveland, OH | 123 |
| Clindamycin Phosphate Other prescribers in Cleveland, OH | 81 |
| Fluocinonide Other prescribers in Cleveland, OH | 77 |
| Hydrocortisone Other prescribers in Cleveland, OH | 63 |
| Dupixent Pen (dupilumab) Other prescribers in Cleveland, OH | 62 |
| Cosentyx Sensoready (2 Pens) (secukinumab) | 51 |
| Mupirocin Other prescribers in Cleveland, OH | 44 |
| Taltz Autoinjector (ixekizumab) | 40 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 20 payments worth $442 in total to this clinician.
| Genzyme Corporation | $74.04 |
|---|---|
| Janssen Biotech, Inc. | $69.78 |
| Regeneron Healthcare Solutions, Inc. | $49.05 |
| Lilly USA, LLC | $43.25 |
| Novartis Pharmaceuticals Corporation | $42.71 |
| Amgen Inc. | $33.22 |
| UCB, Inc. | $29.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.92 |
| Food and Beverage | $442 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.